Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency | MicrobiomeTrials← Back to trialsNCT06477159
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2024-02-01Est. Completion: 2027-09-30
Enrollment target: 30 participants Locations- University of Southern California, Los Angeles, California, United States
- University of Illinois Chicago, Chicago, Illinois, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- New York University Langone Medical Center, New York, New York, United States
- The Ohio State University, Columbus, Ohio, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
In this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called "enzymes"), is being investigated …
Long Beach, United StatesEst. completion Jul 2027
Cystic Fibrosis (CF)Pancreatic InsufficiencyPancreas DiseaseExocrine Pancreatic InsufficiencyExocrine Pancreatic Insufficiency in Subjects With Cystic FibrosisCFTR Gene Mutation
The goal of this clinical trial is to evaluate the safety of stopping pancreatic enzyme replacement therapy (PERT) in ch…
Indianapolis, United StatesCompleted Aug 8, 2025